, Volume 66, Issue 14, pp 1797-1806
Date: 12 Sep 2012

Antistaphylococcal Vaccines and Immunoglobulins

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


Staphylococci are among the most frequently encountered pathogens in both the inpatient and the outpatient setting. Management of infections caused by these organisms is complicated by the increasingly common resistance of staphylococcal pathogens to commonly used antibacterials. As a consequence, novel approaches to prevention and treatment are urgently required. Such approaches include the development of vaccines and immunoglobulin preparations targeted at virulence factors expressed in vivo by staphylococci. This article reviews the biopharmaceutical progress made to date in this field and suggests approaches to further progress.